SEC Filings TLDR

On October 17, 2025, a Form 144 filing was submitted for Robert B. Larson, an officer at Albertsons Companies, Inc. The filing pertains to the vesting of 17,815 Class A restricted stock units, which were acquired on February 22, 2025, as part of compensation. The aggregate market value of these securities is approximat...

Philip Daniele, an officer and director of AutoZone Inc., has filed a Form 144 indicating the intent to sell 2,533 shares of common stock. The shares were acquired through an option granted on September 26, 2017, and are planned to be sold on October 17, 2025. The aggregate market value of the shares is approximately $...

Peter W. Getsinger, a director of Argan, Inc., has filed a Form 144 notice regarding the sale of securities. On October 17, 2025, Getsinger exercised options to acquire 2,000 shares of common stock under a registered plan. Additionally, Getsinger sold 1,000 shares on September 19, 2025, for $264,535.10 and 2,609 shares...

Aparna Bawa, an affiliate of Zoom Video Communications, Inc., has filed a Form 144 with the SEC to sell 10,528 Class A Common shares acquired through RSU vesting. The shares, valued at approximately $837,081, are to be sold by the Bawa Family Trust, with Aparna Bawa as the trustee. The sale is planned for October 16, 2...

RA Capital Nexus Fund, L.P., a director and 10% stockholder of Vor Biopharma Inc., has filed a Form 144 indicating the intent to sell 24,916 shares of common stock. The shares were acquired through private financing transactions on 02/05/2020 and 06/30/2020. The aggregate market value of the shares to be sold is approx...

RA Capital Healthcare Fund LP, a significant shareholder and director of Vor Biopharma Inc., has filed a notice of its intention to sell 126,887 common shares of Vor Biopharma Inc. The shares were acquired through private financing transactions between February 2019 and June 2020. The aggregate market value of the shar...

The filing details the securities transactions of James A. Burke, an officer and director of Vistra Corp. Burke plans to sell 21,355 shares of common stock acquired through options granted on April 9, 2018, with the sale scheduled for October 16, 2025. The aggregate market value of these shares is approximately $4,595,...

MIRELF VI REIT INVESTMENT II, LLC, a former affiliate of VERIS RESIDENTIAL, INC., has reported significant sales of common stock over the past three months. The sales, which occurred between September 9, 2025, and October 3, 2025, involved transactions totaling millions of dollars. The largest single sale occurred on S...

MIRELF VII US SECURITIES LLC, a former affiliate of Veris Residential, Inc., has reported the sale of 115 shares of common stock acquired on December 4, 2018, through an open market purchase. The sale is scheduled for October 16, 2025, with an aggregate market value of $1,700.85. Additionally, MIRELF VII US SECURITIES ...

Mark Barrysmith, an officer at Unity Software Inc., has filed a Form 144 detailing his equity transactions. The filing indicates that Barrysmith plans to sell 802 units of common stock on or around October 16, 2025, with an aggregate market value of $29,048. The securities were acquired through restricted stock lapses ...

Hitesh Ramani, an officer of UiPath Inc., has filed a Form 144 to sell 10,000 shares of common stock acquired through the vesting of restricted stock units. The securities were acquired between January 1, 2024, and October 1, 2025. The sale is scheduled for October 16, 2025, with an aggregate market value of $166,900. ...

Paul Mahon, an officer at United Therapeutics Corporation, has exercised stock options and sold shares of the company's common stock. The filing details the exercise of 11,000 stock options on October 16, 2025, with the shares acquired on the same date. Additionally, the filing reports multiple sales of 11,000 shares e...

The filing details the securities transactions of Martine Rothblatt, the Founder, Chairperson, and Chief Executive Officer of United Therapeutics Corp. The filing includes information on securities to be sold and recent transactions over the past three months. Rothblatt plans to sell 4,000 common shares on October 16, ...

Richard T. Hume, an officer of TD SYNNEX Corporation, plans to sell 76,848 shares of the company's common stock. The sale is part of a selling plan dated July 14, 2025, intended to comply with Rule 10b5-1(c). The shares to be sold were acquired as compensation, including Restricted Stock Units and Stock Options. The ap...

Wayne DeVeydt, a former director of Surgery Partners, Inc., has reported significant securities transactions. On 10/16/2025, DeVeydt acquired 52,946 shares of common stock through equity compensation. Additionally, DeVeydt has engaged in multiple sales of common stock over the past three months, totaling over $11 milli...

The filing details the stock transactions of Benoit Dageville, an officer and director at Snowflake Inc. On October 16, 2025, Dageville plans to sell 25,000 shares of common stock acquired through options granted on December 11, 2019. The aggregate market value of these shares is $6,150,000. Additionally, the filing re...

Ajit Mohan, an officer at Snap Inc, has reported the sale of 28,238 common shares on 10/16/2025 to cover tax obligations from the settlement of vested Restricted Stock Units. The aggregate market value of these shares was $221,117. Additionally, Mohan has disclosed sales of Snap Inc shares in the past three months, inc...

The filing details the stock transactions and plan adoption by Michael Cloonan, a director and officer at Sionna Therapeutics, Inc. On October 16, 2025, Cloonan exercised stock options to acquire 200 common shares. The plan was adopted on May 21, 2025. Additionally, the filing reports significant sales of common shares...

Atlas Venture Fund XI, LP has filed a Form 144 with the SEC, indicating its intention to sell 139,897 shares of Sionna Therapeutics, Inc. common stock. The shares were acquired through a private placement on March 4, 2024. The filing also details the sale of 546,370 shares over the past three months, with transactions ...

Atlas Venture Opportunity Fund II, L.P. has filed a notice of sale of Sionna Therapeutics, Inc. common stock. The filing details the sale of 29,363 shares acquired through a private placement on March 4, 2024. The notice, signed by Ommer Chohan on October 16, 2025, indicates that the securities were sold on the same da...

Margaret Dugan, an officer at Schrodinger, Inc., has reported the vesting and subsequent sale of 1,395 shares of common stock. The shares vested on October 15, 2025, and were sold on October 16, 2025, at an aggregate market value of $29,386.93. The sale was conducted through Fidelity Brokerage Services LLC and included...

The filing details the sale of Class A Common shares by the Edward K Christian Agreement of Trust in Saga Communications Inc. The trust, which holds a 10% stake in the company, sold 761 shares on October 16, 2025, with an aggregate market value of $9,517.52. The shares were originally acquired on August 19, 2022, throu...

Eric Venker, an officer of Roivant Sciences Ltd., plans to sell 318,282 common shares of the company on October 16, 2025, pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025. The shares were acquired through the exercise of options granted on March 26, 2020. The aggregate market value of the shares to be s...

Mark A Goldsmith, a director and officer of Revolution Medicines, Inc., has filed a Form 144 indicating his intention to sell 10,000 shares of common stock acquired through the exercise of stock options. The transaction is scheduled for October 16, 2025, with an aggregate market value of $495,600. Additionally, Goldsmi...

The filing reports that Halverson Kenneth, a director of Richardson Electronics, Ltd., plans to sell 4,200 shares of common stock on October 16, 2025. The shares were acquired through purchases on August 8, 2024, and October 15, 2024. The aggregate market value of the shares to be sold is $49,581. The filing also confi...